Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GPhA legislative staffers

This article was originally published in The Tan Sheet

Executive Summary

Generic Pharmaceutical Association adds two legislative staffers in advance of 108th Congress. VP-Policy & Public Affairs Christine Simmon joins GPhA from BlueCross BlueShield, where she served as a senior policy analyst. Suzanne Charleston is GPhA's new director of government relations; she previously held the same position at the Pharmaceutical Care Management Association. GPhA's legislative agenda is centered on modifications to Hatch/Waxman; Sen. Orrin Hatch (R-Utah), who will resume chairmanship of the Judiciary Committee, has expressed interest in considering generic drug reforms (1"The Tan Sheet" Nov. 11, 2002, p. 11)...

You may also be interested in...

OTC Tax Deductibility Could Gain Favor In 108th Congress

CHPA believes the Republican majority in the Senate will be more willing to consider the association's proposal to make OTC drug purchases tax deductible

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

venBio Raises $394m To Fund Biopharmas Through Human Proof-Of-Concept

Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts